Skip to main content
Article
Phase I Trial Results Testing Adoptively Transferred T Cells Expressing CD20-Specific Chimeric Antigen Receptors Containing CD28 and CD137 Costimulatory Domains In Patients with Mantle Cell Lymphoma and Indolent Lymphoma
Blood (2010)
  • Brian G. Till, Fred Hutchinson Cancer Research Center
  • Michael C. Jensen, Seattle Children's
  • Xiaojun Qian, Fred Hutchinson Cancer Research Center
  • Jinjuan Wang, Fred Hutchinson Cancer Research Center
  • Ajay K Gopal, University of Washington
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Catherine G. Lindgren, Seattle Children's
  • Yukang Lin, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Lihua E Budde, Fred Hutchinson Cancer Research Center
  • Andrew Raubitschek, City of Hope National Medical Center
  • Stephen Forman, City of Hope National Medical Center
  • Philip Greenberg, Fred Hutchinson Cancer Research Center
  • Stanley R. Riddell, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Publication Date
November 19, 2010
Citation Information
Brian G. Till, Michael C. Jensen, Xiaojun Qian, Jinjuan Wang, et al.. "Phase I Trial Results Testing Adoptively Transferred T Cells Expressing CD20-Specific Chimeric Antigen Receptors Containing CD28 and CD137 Costimulatory Domains In Patients with Mantle Cell Lymphoma and Indolent Lymphoma" Blood Vol. 116 Iss. 21 (2010) p. 561 - 561
Available at: http://works.bepress.com/john-pagel/186/